Therapy with Efavirenz plus Indinavir in Patients with Extensive Prior Nucleoside Reverse‐Transcriptase Inhibitor Experience: A Randomized, Double‐Blind, Placebo‐Controlled Trial

Name: Work Video:
Duration: 3 min 30 s
David W. Haas; W. Jeffrey Fessel; Robert Delapenha; Harold A. Kessler; Daniel Seekins; Mark Kaplan; Nancy Ruíz; Lynn Ploughman; Dominic Labriola; Douglas J. Manion
{'id': 'https://openalex.org/W1965160986', 'doi': 'https://doi.org/10.1086/318083', 'title': 'Therapy with Efavirenz plus Indinavir in Patients with Extensive Prior Nucleoside Reverse‐Transcriptase Inhibitor Experience: A Randomized, Double‐Blind, Placebo‐Controlled Trial', 'display_name': 'Therapy with Efavirenz plus Indinavir in Patients with Extensive Prior Nucleoside Reverse‐Transcriptase Inhibitor Experience: A Randomized, Double‐Blind, Placebo‐Controlled Trial', 'publication_year': 2001, 'publication_date': '2001-02-01', 'ids': {'openalex': 'https://openalex.org/W1965160986', 'doi': 'https://doi.org/10.1086/318083', 'mag': '1965160986', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/11133370'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1086/318083', 'pdf_url': 'https://academic.oup.com/jid/article-pdf/183/3/392/18000918/183-3-392.pdf', 'source': {'id': 'https://openalex.org/S54542293', 'display_name': 'The Journal of Infectious Diseases', 'issn_l': '0022-1899', 'issn': ['0022-1899', '1537-6613'], 'is_oa': False, 'is_in_doaj': False, 'is_indexed_in_scopus': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310311648', 'host_organization_name': 'Oxford University Press', 'host_organization_lineage': ['https://openalex.org/P4310311647', 'https://openalex.org/P4310311648'], 'host_organization_lineage_names': ['University of Oxford', 'Oxford University Press'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://academic.oup.com/jid/article-pdf/183/3/392/18000918/183-3-392.pdf', 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5020915167', 'display_name': 'David W. Haas', 'orcid': 'https://orcid.org/0000-0002-5813-1594'}, 'institutions': [{'id': 'https://openalex.org/I200719446', 'display_name': 'Vanderbilt University', 'ror': 'https://ror.org/02vm5rt34', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I200719446']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'David\xa0W. Haas', 'raw_affiliation_strings': ['Division of Infectious Diseases, Vanderbilt University, Nashville, Tennessee'], 'affiliations': [{'raw_affiliation_string': 'Division of Infectious Diseases, Vanderbilt University, Nashville, Tennessee', 'institution_ids': ['https://openalex.org/I200719446']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5078037818', 'display_name': 'W. Jeffrey Fessel', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210122929', 'display_name': 'Kaiser Permanente San Francisco Medical Center', 'ror': 'https://ror.org/02fxsj090', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343052199', 'https://openalex.org/I4210122929']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'W.\xa0Jeffrey Fessel', 'raw_affiliation_strings': ['Research Unit, Kaiser Permanente Medical Center, San Francisco, California'], 'affiliations': [{'raw_affiliation_string': 'Research Unit, Kaiser Permanente Medical Center, San Francisco, California', 'institution_ids': ['https://openalex.org/I4210122929']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5108596141', 'display_name': 'Robert Delapenha', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2801534649', 'display_name': 'AIDS Clinical Trials Group', 'ror': 'https://ror.org/02yz1n812', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I2801534649']}, {'id': 'https://openalex.org/I137853757', 'display_name': 'Howard University', 'ror': 'https://ror.org/05gt1vc06', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I137853757']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Robert\xa0A. Delapenha', 'raw_affiliation_strings': ['AIDS Clinical Trials Unit, Howard University, Washington, DC'], 'affiliations': [{'raw_affiliation_string': 'AIDS Clinical Trials Unit, Howard University, Washington, DC', 'institution_ids': ['https://openalex.org/I2801534649', 'https://openalex.org/I137853757']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5109224654', 'display_name': 'Harold A. Kessler', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210152177', 'display_name': 'Center for Clinical Research (United States)', 'ror': 'https://ror.org/05fnzzk18', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210152177']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Harold Kessler', 'raw_affiliation_strings': ['Chicago Center for Clinical Research, Chicago, Illinois'], 'affiliations': [{'raw_affiliation_string': 'Chicago Center for Clinical Research, Chicago, Illinois', 'institution_ids': ['https://openalex.org/I4210152177']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5039636581', 'display_name': 'Daniel Seekins', 'orcid': None}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Daniel Seekins', 'raw_affiliation_strings': ["St. Joseph's Comprehensive Research Institute, Tampa, Florida"], 'affiliations': [{'raw_affiliation_string': "St. Joseph's Comprehensive Research Institute, Tampa, Florida", 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5109199869', 'display_name': 'Mark Kaplan', 'orcid': None}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Mark Kaplan', 'raw_affiliation_strings': ['Center of AIDS Research and Treatment, Division of Infectious Diseases, North Shore Health Systems, Manhasset, New York'], 'affiliations': [{'raw_affiliation_string': 'Center of AIDS Research and Treatment, Division of Infectious Diseases, North Shore Health Systems, Manhasset, New York', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5103371010', 'display_name': 'Nancy Ruíz', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1316910977', 'display_name': 'DuPont (United States)', 'ror': 'https://ror.org/03g3m1w62', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1316910977']}, {'id': 'https://openalex.org/I210824098', 'display_name': 'Wilmington University', 'ror': 'https://ror.org/00jrtvk29', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I210824098']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Nancy\xa0M. Ruiz', 'raw_affiliation_strings': ['DuPont Pharmaceuticals Co., Wilmington, Delaware'], 'affiliations': [{'raw_affiliation_string': 'DuPont Pharmaceuticals Co., Wilmington, Delaware', 'institution_ids': ['https://openalex.org/I1316910977', 'https://openalex.org/I210824098']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5082534399', 'display_name': 'Lynn Ploughman', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I210824098', 'display_name': 'Wilmington University', 'ror': 'https://ror.org/00jrtvk29', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I210824098']}, {'id': 'https://openalex.org/I1316910977', 'display_name': 'DuPont (United States)', 'ror': 'https://ror.org/03g3m1w62', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1316910977']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Lynn\xa0M. Ploughman', 'raw_affiliation_strings': ['DuPont Pharmaceuticals Co., Wilmington, Delaware'], 'affiliations': [{'raw_affiliation_string': 'DuPont Pharmaceuticals Co., Wilmington, Delaware', 'institution_ids': ['https://openalex.org/I210824098', 'https://openalex.org/I1316910977']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5082097483', 'display_name': 'Dominic Labriola', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I210824098', 'display_name': 'Wilmington University', 'ror': 'https://ror.org/00jrtvk29', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I210824098']}, {'id': 'https://openalex.org/I1316910977', 'display_name': 'DuPont (United States)', 'ror': 'https://ror.org/03g3m1w62', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1316910977']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Dominic\xa0F. Labriola', 'raw_affiliation_strings': ['DuPont Pharmaceuticals Co., Wilmington, Delaware'], 'affiliations': [{'raw_affiliation_string': 'DuPont Pharmaceuticals Co., Wilmington, Delaware', 'institution_ids': ['https://openalex.org/I210824098', 'https://openalex.org/I1316910977']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5069183781', 'display_name': 'Douglas J. Manion', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I210824098', 'display_name': 'Wilmington University', 'ror': 'https://ror.org/00jrtvk29', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I210824098']}, {'id': 'https://openalex.org/I1316910977', 'display_name': 'DuPont (United States)', 'ror': 'https://ror.org/03g3m1w62', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1316910977']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Douglas\xa0J. Manion', 'raw_affiliation_strings': ['DuPont Pharmaceuticals Co., Wilmington, Delaware'], 'affiliations': [{'raw_affiliation_string': 'DuPont Pharmaceuticals Co., Wilmington, Delaware', 'institution_ids': ['https://openalex.org/I210824098', 'https://openalex.org/I1316910977']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 7, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 4320, 'currency': 'USD', 'value_usd': 4320, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 2.332, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 38, 'citation_normalized_percentile': {'value': 0.728499, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 90, 'max': 91}, 'biblio': {'volume': '183', 'issue': '3', 'first_page': '392', 'last_page': '400'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10526', 'display_name': 'HIV/AIDS drug development and treatment', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2725', 'display_name': 'Infectious Diseases'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10526', 'display_name': 'HIV/AIDS drug development and treatment', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2725', 'display_name': 'Infectious Diseases'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10112', 'display_name': 'HIV Research and Treatment', 'score': 0.9997, 'subfield': {'id': 'https://openalex.org/subfields/2406', 'display_name': 'Virology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10082', 'display_name': 'HIV/AIDS Research and Interventions', 'score': 0.9957, 'subfield': {'id': 'https://openalex.org/subfields/2725', 'display_name': 'Infectious Diseases'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/efavirenz', 'display_name': 'Efavirenz', 'score': 0.961696}, {'id': 'https://openalex.org/keywords/indinavir', 'display_name': 'Indinavir', 'score': 0.9589819}, {'id': 'https://openalex.org/keywords/reverse-transcriptase-inhibitor', 'display_name': 'Reverse-transcriptase inhibitor', 'score': 0.6669142}, {'id': 'https://openalex.org/keywords/concomitant', 'display_name': 'Concomitant', 'score': 0.5634713}, {'id': 'https://openalex.org/keywords/protease-inhibitor', 'display_name': 'Protease inhibitor (pharmacology)', 'score': 0.48843566}], 'concepts': [{'id': 'https://openalex.org/C2781432083', 'wikidata': 'https://www.wikidata.org/wiki/Q422645', 'display_name': 'Efavirenz', 'level': 5, 'score': 0.961696}, {'id': 'https://openalex.org/C2777210460', 'wikidata': 'https://www.wikidata.org/wiki/Q425490', 'display_name': 'Indinavir', 'level': 5, 'score': 0.9589819}, {'id': 'https://openalex.org/C27081682', 'wikidata': 'https://www.wikidata.org/wiki/Q269829', 'display_name': 'Placebo', 'level': 3, 'score': 0.7518854}, {'id': 'https://openalex.org/C2777351918', 'wikidata': 'https://www.wikidata.org/wiki/Q421559', 'display_name': 'Reverse-transcriptase inhibitor', 'level': 5, 'score': 0.6669142}, {'id': 'https://openalex.org/C2779384505', 'wikidata': 'https://www.wikidata.org/wiki/Q17007513', 'display_name': 'Concomitant', 'level': 2, 'score': 0.5634713}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.55628186}, {'id': 'https://openalex.org/C90924648', 'wikidata': 'https://www.wikidata.org/wiki/Q120569', 'display_name': 'Gastroenterology', 'level': 1, 'score': 0.5295927}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.5155794}, {'id': 'https://openalex.org/C2781143361', 'wikidata': 'https://www.wikidata.org/wiki/Q55761529', 'display_name': 'Protease inhibitor (pharmacology)', 'level': 5, 'score': 0.48843566}, {'id': 'https://openalex.org/C159047783', 'wikidata': 'https://www.wikidata.org/wiki/Q7215', 'display_name': 'Virology', 'level': 1, 'score': 0.43487656}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.40594357}, {'id': 'https://openalex.org/C142462285', 'wikidata': 'https://www.wikidata.org/wiki/Q2528140', 'display_name': 'Viral load', 'level': 3, 'score': 0.35471547}, {'id': 'https://openalex.org/C2522874641', 'wikidata': 'https://www.wikidata.org/wiki/Q808', 'display_name': 'Virus', 'level': 2, 'score': 0.20231524}, {'id': 'https://openalex.org/C2993143319', 'wikidata': 'https://www.wikidata.org/wiki/Q583050', 'display_name': 'Antiretroviral therapy', 'level': 4, 'score': 0.16389918}, {'id': 'https://openalex.org/C142724271', 'wikidata': 'https://www.wikidata.org/wiki/Q7208', 'display_name': 'Pathology', 'level': 1, 'score': 0.08530769}, {'id': 'https://openalex.org/C204787440', 'wikidata': 'https://www.wikidata.org/wiki/Q188504', 'display_name': 'Alternative medicine', 'level': 2, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D019380', 'descriptor_name': 'Anti-HIV Agents', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D015658', 'descriptor_name': 'HIV Infections', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D015497', 'descriptor_name': 'HIV-1', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D019469', 'descriptor_name': 'Indinavir', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D010078', 'descriptor_name': 'Oxazines', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D018894', 'descriptor_name': 'Reverse Transcriptase Inhibitors', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D000328', 'descriptor_name': 'Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000480', 'descriptor_name': 'Alkynes', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019380', 'descriptor_name': 'Anti-HIV Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D048588', 'descriptor_name': 'Benzoxazines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018791', 'descriptor_name': 'CD4 Lymphocyte Count', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003521', 'descriptor_name': 'Cyclopropanes', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004311', 'descriptor_name': 'Double-Blind Method', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004359', 'descriptor_name': 'Drug Therapy, Combination', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015658', 'descriptor_name': 'HIV Infections', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015497', 'descriptor_name': 'HIV-1', 'qualifier_ui': 'Q000502', 'qualifier_name': 'physiology', 'is_major_topic': False}, {'descriptor_ui': 'D015497', 'descriptor_name': 'HIV-1', 'qualifier_ui': 'Q000302', 'qualifier_name': 'isolation & purification', 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019469', 'descriptor_name': 'Indinavir', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010078', 'descriptor_name': 'Oxazines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D012367', 'descriptor_name': 'RNA, Viral', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D012367', 'descriptor_name': 'RNA, Viral', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': False}, {'descriptor_ui': 'D018894', 'descriptor_name': 'Reverse Transcriptase Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016896', 'descriptor_name': 'Treatment Outcome', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1086/318083', 'pdf_url': 'https://academic.oup.com/jid/article-pdf/183/3/392/18000918/183-3-392.pdf', 'source': {'id': 'https://openalex.org/S54542293', 'display_name': 'The Journal of Infectious Diseases', 'issn_l': '0022-1899', 'issn': ['0022-1899', '1537-6613'], 'is_oa': False, 'is_in_doaj': False, 'is_indexed_in_scopus': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310311648', 'host_organization_name': 'Oxford University Press', 'host_organization_lineage': ['https://openalex.org/P4310311647', 'https://openalex.org/P4310311648'], 'host_organization_lineage_names': ['University of Oxford', 'Oxford University Press'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/11133370', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_indexed_in_scopus': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1086/318083', 'pdf_url': 'https://academic.oup.com/jid/article-pdf/183/3/392/18000918/183-3-392.pdf', 'source': {'id': 'https://openalex.org/S54542293', 'display_name': 'The Journal of Infectious Diseases', 'issn_l': '0022-1899', 'issn': ['0022-1899', '1537-6613'], 'is_oa': False, 'is_in_doaj': False, 'is_indexed_in_scopus': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310311648', 'host_organization_name': 'Oxford University Press', 'host_organization_lineage': ['https://openalex.org/P4310311647', 'https://openalex.org/P4310311648'], 'host_organization_lineage_names': ['University of Oxford', 'Oxford University Press'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.84, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 32, 'referenced_works': ['https://openalex.org/W1618865275', 'https://openalex.org/W1997808475', 'https://openalex.org/W1997844736', 'https://openalex.org/W2003199949', 'https://openalex.org/W2008383946', 'https://openalex.org/W2008954911', 'https://openalex.org/W2010881564', 'https://openalex.org/W2011630381', 'https://openalex.org/W2012139740', 'https://openalex.org/W2021037491', 'https://openalex.org/W2029152314', 'https://openalex.org/W2034057501', 'https://openalex.org/W2057023456', 'https://openalex.org/W2057481372', 'https://openalex.org/W2062388675', 'https://openalex.org/W2063950143', 'https://openalex.org/W2113651012', 'https://openalex.org/W2115768301', 'https://openalex.org/W2138294993', 'https://openalex.org/W2141883500', 'https://openalex.org/W2144838726', 'https://openalex.org/W2159701055', 'https://openalex.org/W2161558889', 'https://openalex.org/W2171141994', 'https://openalex.org/W2183940924', 'https://openalex.org/W2321852728', 'https://openalex.org/W2329393410', 'https://openalex.org/W2332835113', 'https://openalex.org/W2339219218', 'https://openalex.org/W2400098770', 'https://openalex.org/W305241044', 'https://openalex.org/W49232095'], 'related_works': ['https://openalex.org/W3028205985', 'https://openalex.org/W2414730574', 'https://openalex.org/W2321852728', 'https://openalex.org/W2143210567', 'https://openalex.org/W2141680152', 'https://openalex.org/W2105361514', 'https://openalex.org/W2095332267', 'https://openalex.org/W1969676506', 'https://openalex.org/W1965160986', 'https://openalex.org/W1531772436'], 'abstract_inverted_index': {'A': [0], 'randomized,': [1], 'double-blind,': [2], 'placebo-controlled': [3], 'trial': [4], 'compared': [5], 'efavirenz': [6, 93, 117, 127, 135], '(600': [7], 'mg': [8, 15, 27], 'every': [9, 16, 28], '24': [10, 22, 81], 'h)': [11, 18, 23, 30], 'plus': [12, 24, 136], 'indinavir': [13, 25, 137], '(1000': [14], '8': [17, 29], 'with': [19, 138], 'placebo': [20, 97, 119], '(every': [21], '(800': [26], 'among': [31], '327': [32], 'nucleoside': [33], 'analogue': [34], 'reverse-transcriptase': [35], 'inhibitor': [36, 65], '(NRTI)—experienced': [37], 'human': [38], 'immunodeficiency': [39], 'virus': [40], '(HIV)—infected': [41], 'adults.': [42], 'Patients': [43, 69], 'received': [44], '⩽2': [45], 'concomitant': [46, 139], 'NRTIs.': [47], 'Eligible': [48], 'patients': [49], 'had': [50, 70], 'CD4': [51, 102], 'cell': [52, 103], 'counts': [53], '>50': [54], 'cells/mm3,': [55], '>10,000': [56], 'plasma': [57, 83], 'HIV-1': [58, 84], 'RNA': [59, 85], 'copies/mL,': [60], 'and': [61, 111, 118], 'no': [62], 'prior': [63, 77], 'protease': [64], 'or': [66], 'non-NRTI': [67], 'therapy.': [68, 79], 'a': [71], 'mean': [72], 'of': [73, 76, 92, 96], '2.8': [74], 'years': [75], 'NRTI': [78], 'At': [80], 'weeks,': [82], 'level': [86], 'was': [87], '<400': [88], 'copies/mL': [89], 'in': [90, 116, 126], '68.2%': [91], 'versus': [94], '52.4%': [95], 'recipients': [98, 128], '(P': [99, 122], '=': [100, 123], '.004).': [101], 'count': [104], 'increases': [105], 'were': [106, 129], '104': [107], '±': [108, 113], '9': [109], 'cells/mm3': [110, 115], '77': [112], '10': [114], 'recipients,': [120], 'respectively': [121], '.023).': [124], 'Responses': [125], 'sustained': [130], 'at': [131], '48': [132], 'weeks.': [133], 'Thus,': [134], 'NRTIs': [140], 'is': [141], 'effective': [142], 'therapy': [143], 'for': [144], 'NRTI-experienced': [145], 'patients.': [146]}, 'abstract_inverted_index_v3': None, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1965160986', 'counts_by_year': [{'year': 2023, 'cited_by_count': 1}, {'year': 2022, 'cited_by_count': 1}, {'year': 2020, 'cited_by_count': 1}, {'year': 2017, 'cited_by_count': 1}, {'year': 2015, 'cited_by_count': 5}, {'year': 2014, 'cited_by_count': 1}], 'updated_date': '2025-01-18T14:06:16.599924', 'created_date': '2016-06-24'}
Publication Information

Basic Information

Access and Citation

AI Researcher Chatbot

Primary Location

Authors

Topics

Keywords

Related Works
